| Balance sheet (USD) | Q2 2026 ended Jun 30, 2026 | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6.57B | 9.39B | 5.23B | 5.63B | 6.47B | 5.17B | 5.52B | 7.26B |
| Short-term investments | 28.00M | 42.00M | 0 | 1.00M | 31.00M | 28.00M | ||
| Receivables | 13.82B | 12.48B | 12.59B | 12.77B | 12.64B | 12.48B | 10.92B | 11.47B |
| Inventory | 5.13B | 5.05B | 4.95B | 4.94B | 4.96B | 4.53B | 4.18B | 4.45B |
| Total current assets | 33.67B | 33.53B | 29.06B | 28.54B | 29.26B | 27.68B | 25.58B | 27.79B |
| Property, plant and equipment | 5.80B | 5.69B | 5.63B | 5.48B | 5.28B | 5.24B | 5.13B | 5.14B |
| Goodwill and intangibles | 84.66B | 86.44B | 88.28B | 89.94B | 92.67B | 93.77B | 95.02B | 101.94B |
| Total assets | 135.12B | 136.46B | 133.96B | 133.90B | 137.18B | 136.16B | 135.16B | 143.42B |
| Accounts payable | 33.30B | 33.77B | 3.59B | 33.62B | 32.24B | 31.04B | 2.94B | 30.49B |
| Total current liabilities | 41.64B | 42.10B | 43.29B | 39.39B | 39.77B | 36.40B | 38.75B | 43.06B |
| Long-term debt | 62.48B | 64.53B | 58.94B | 62.97B | 62.96B | 64.53B | 60.34B | 58.51B |
| Total liabilities | 141.05B | 143.12B | 137.23B | 136.54B | 137.37B | 134.75B | 131.84B | 137.39B |
| Retained earnings | -17.33B | -17.87B | -15.49B | -14.23B | -11.50B | -9.53B | -7.90B | -4.96B |
| Shareholders' equity | -5.93B | -6.66B | -3.27B | -2.64B | -183.00M | 1.42B | 3.33B | 6.03B |
| Total debt | 62.48B | 64.53B | 61.44B | 66.76B | 68.52B | 66.12B | 60.34B | 58.51B |
| Net debt | 55.91B | 55.14B | 56.21B | 61.13B | 62.05B | 60.95B | 54.82B | 51.25B |
From AbbVie's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.